You are here

Roche

Roche ties a $387M knot with Warp Drive Bio in collaboration spotlighting new classes of antibiotics

Roche ties a $387M knot with Warp Drive Bio in collaboration spotlighting new classes of antibiotics

Endpoints

Flag link:

'Double whammy' for Roche as manufacturing patent losses loom

'Double whammy' for Roche as manufacturing patent losses loom

Reuters

Cabilly patents

drug manufacturing

Flag link:

Corrected: What Q3 earnings will look like for 5 pharma giants

Corrected: What Q3 earnings will look like for 5 pharma giants

Biopharma Dive

Flag link:

No sale for Novartis' $14B Roche stake, but the revamp's not done

No sale for Novartis' $14B Roche stake, but the revamp's not done

Fierce Pharma

Flag link:

Roche's Tecentriq cedes bladder-cancer share to Keytruda in wake of trial misfire

Roche's Tecentriq cedes bladder-cancer share to Keytruda in wake of trial misfire

Fierce Pharma

Flag link:

First test to screen blood donations for Zika virus wins FDA nod

First test to screen blood donations for Zika virus wins FDA nod

Drug Delivery Business News

blood donations

Flag link:

Most new cancer meds haven't proved they can improve or extend lives: study

Most new cancer meds haven't proved they can improve or extend lives: study

Fierce Pharma

Flag link:

1 Great Biotech Stock You Have Never Heard Of

1 Great Biotech Stock You Have Never Heard Of

Motley Fool

Halozyme Therapeutics

Bristol-Myers Squibb

Flag link:

FDA puts Roche's Perjeta-Herceptin combo in the fast lane, but will it deliver?

FDA puts Roche's Perjeta-Herceptin combo in the fast lane, but will it deliver?

Fierce Pharma

Perjeta-Herceptin

Flag link:

Apple, JNJ, Roche among companies selected for FDA digital health precertification pilot

Apple, JNJ, Roche among companies selected for FDA digital health precertification pilot

BioPharma Dive

digital healthcare

Flag link:

AbbVie, Roche to seek broader market for leukemia drug after trial success

AbbVie, Roche to seek broader market for leukemia drug after trial success

BioPharma Dive

clinical trials

chronic lymphocytic leukemia

Flag link:

FDA Clears Biotech Drug Copycats, But Buying Them Isn’t So Easy

FDA Clears Biotech Drug Copycats, But Buying Them Isn’t So Easy

Bloomberg

Flag link:

Samsung Bioepis first to secure EMA backing for Herceptin biosimilar

Samsung Bioepis first to secure EMA backing for Herceptin biosimilar

BioPharma Dive

Samsung Bioepis

Flag link:

FDA adds two Roche studies to its growing list of partial clinical holds in wake of Keytruda deaths

FDA adds two Roche studies to its growing list of partial clinical holds in wake of Keytruda deaths

Endpoints

clinical trials

Flag link:

Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?

Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?

Motley Fool

Teva Pharmaceutical

Unitedhealthcare Group

Bristol-Myers Squibb

Flag link:

FDA commish cheers on biosimilars as Amgen, Allergan score OK for knockoff of Roche’s Avastin

FDA commish cheers on biosimilars as Amgen, Allergan score OK for knockoff of Roche’s Avastin

Endpoints

Flag link:

FDA says Tecentriq won't lose its bladder cancer nod despite phase 3 failure, Roche reports

FDA says Tecentriq won't lose its bladder cancer nod despite phase 3 failure, Roche reports

Fierce Pharma

clinical trials

Flag link:

Roche gets hit with another big R&D setback as a prospective AMD blockbuster flops in PhIII

Roche gets hit with another big R&D setback as a prospective AMD blockbuster flops in PhIII

Endpoints

Flag link:

An accurate analysis of the differences between Swiss companies Roche and Novartis

An accurate analysis of the differences between Swiss companies Roche and Novartis

GoInPharma

Flag link:

Parkinson's Now a Hot Therapeutic Area: What's Up Lately?

Parkinson's Now a Hot Therapeutic Area: What's Up Lately?

Yahoo/Zacks.com

Parkinson's Disease

Teva Pharmaceutial

Adamas Pharmaceuticals

Flag link: